Merial acquires Newport Laboratories

 Resize text         Printer-friendly version of this article Printer-friendly version of this article

Merial, the animal health division of Sanofi, has announced its acquisition of Newport Laboratories, a Worthington, Minn.-based privately held company and manufacturer of autogenous vaccines with a focus on swine and cattle production markets.

Newport Laboratories assists veterinarians and livestock producers in their efforts to address animal health problems through diagnostic testing and production of veterinary biologics. According to the company’s website, Newport Laboratories is the nation's leading manufacturer of autogenous biologics.

“Joining forces with Merial allows us to expand our expertise in the market and enhance the profitability of our customers through solution-based animal healthcare offerings,” said Randy Simonson, chief operating officer, Newport Laboratories. “We will also be able to reach untapped markets in the U.S., and eventually bring our expertise to the rest of the world.”

“Newport has demonstrated over time the ability to screen field samples and produce autogenous vaccines from large integrated producers with remarkable efficiency,” said Jose Barella, chief executive officer of Merial. “The combination of Newport’s expertise and Merial’s strength in technology and geographic footprint will reinforce our exposure to the swine market segment and illustrates our strategy to expand our position in treatments for production animals.”

Newport Laboratories’ diagnostic technology assists in identifying pathogens while the company’s novel manufacturing technologies are used to produce autogenous vaccines, offering veterinarians and livestock producers alternative methods to help prevent diseases in food animals.  Due to this specific positioning, Newport has developed a unique relationship in the U.S. with swine producers.

This acquisition will enable Merial to expand its production animal business in the U.S. while providing a unique opportunity to meet the needs of U.S. swine producers.  Newport Laboratories will continue to operate from its Worthington site and maintain its high level of service to its customers.

Source: Merial



Comments (0) Leave a comment 

Name
e-Mail (required)
Location

Comment:

characters left


OptiPhos 1000

OptiPhos 1000,OptiPhos 1000 PF, a phytase, will increase the digestibility of phytic-bound phosphorus in poultry and swine rations. OptiPhos will ... Read More

View all Products in this segment

View All Buyers Guides

Feedback Form
Generate Leads